Study of the efficacy of the drug memantine in the treatment of fibromialgia
- Conditions
- FibromialgiaTherapeutic area: Body processes [G] - Bones and nerves physological processes [G11]MedDRA version: 14.0Level: PTClassification code 10048439Term: FibromyalgiaSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
- Registration Number
- EUCTR2011-000802-23-ES
- Lead Sponsor
- Javier García Campayo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 10
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Timepoint(s) of evaluation of this end point: Basal, 1 month, 3 months;Main Objective: Evaluate the efficacy of memantine in the reduction of glutamate brain levels in patients with fibromialgia;Secondary Objective: Evaluate the efficacy of memantine in the treatnebt of the pain and other symptoms in fibromialgia;Primary end point(s):
- Secondary Outcome Measures
Name Time Method Timepoint(s) of evaluation of this end point: Basal, 1 month, 3 months